Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram effects on cerebral glucose metabolism in panic disorder
NCT00767871Phase 4Completed
- Sponsor
- Samsung Medical Center
- Start
- Mar 2007
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in panic disorder, sponsored by Samsung Medical Center. Started Mar 2007; status: completed.
02
Drugs
escitalopram
03
Conditions
panic disorder
Beyond the preview
Go deeper on NCT00767871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00767871.